nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—NR3C2—Betamethasone—ankylosing spondylitis	0.314	0.327	CbGbCtD
Nimodipine—NR3C2—Prednisolone—ankylosing spondylitis	0.31	0.322	CbGbCtD
Nimodipine—NR3C2—Dexamethasone—ankylosing spondylitis	0.183	0.19	CbGbCtD
Nimodipine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0432	0.0449	CbGbCtD
Nimodipine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0222	0.0231	CbGbCtD
Nimodipine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0216	0.0224	CbGbCtD
Nimodipine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0168	0.0175	CbGbCtD
Nimodipine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0145	0.015	CbGbCtD
Nimodipine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0143	0.0148	CbGbCtD
Nimodipine—CYP3A4—Prednisone—ankylosing spondylitis	0.0135	0.014	CbGbCtD
Nimodipine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00841	0.00875	CbGbCtD
Nimodipine—Acne—Prednisolone—ankylosing spondylitis	0.000794	0.0206	CcSEcCtD
Nimodipine—Acne—Triamcinolone—ankylosing spondylitis	0.000731	0.0189	CcSEcCtD
Nimodipine—Acne—Methylprednisolone—ankylosing spondylitis	0.000729	0.0189	CcSEcCtD
Nimodipine—Deep vein thrombosis—Methotrexate—ankylosing spondylitis	0.000667	0.0173	CcSEcCtD
Nimodipine—Acne—Betamethasone—ankylosing spondylitis	0.000663	0.0172	CcSEcCtD
Nimodipine—Acne—Dexamethasone—ankylosing spondylitis	0.000663	0.0172	CcSEcCtD
Nimodipine—Fluid retention—Prednisolone—ankylosing spondylitis	0.000635	0.0164	CcSEcCtD
Nimodipine—Wheezing—Triamcinolone—ankylosing spondylitis	0.000597	0.0155	CcSEcCtD
Nimodipine—Fluid retention—Triamcinolone—ankylosing spondylitis	0.000584	0.0151	CcSEcCtD
Nimodipine—Fluid retention—Methylprednisolone—ankylosing spondylitis	0.000582	0.0151	CcSEcCtD
Nimodipine—Acne—Prednisone—ankylosing spondylitis	0.000577	0.015	CcSEcCtD
Nimodipine—Cardiac failure congestive—Prednisolone—ankylosing spondylitis	0.000535	0.0139	CcSEcCtD
Nimodipine—Fluid retention—Dexamethasone—ankylosing spondylitis	0.00053	0.0137	CcSEcCtD
Nimodipine—Fluid retention—Betamethasone—ankylosing spondylitis	0.00053	0.0137	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.000512	0.0133	CcSEcCtD
Nimodipine—Cardiac failure congestive—Triamcinolone—ankylosing spondylitis	0.000492	0.0128	CcSEcCtD
Nimodipine—Cardiac failure congestive—Methylprednisolone—ankylosing spondylitis	0.000491	0.0127	CcSEcCtD
Nimodipine—Fluid retention—Prednisone—ankylosing spondylitis	0.000461	0.012	CcSEcCtD
Nimodipine—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.000447	0.0116	CcSEcCtD
Nimodipine—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.000447	0.0116	CcSEcCtD
Nimodipine—Sweating increased—Prednisolone—ankylosing spondylitis	0.000409	0.0106	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.000393	0.0102	CcSEcCtD
Nimodipine—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.000389	0.0101	CcSEcCtD
Nimodipine—Sweating increased—Triamcinolone—ankylosing spondylitis	0.000376	0.00974	CcSEcCtD
Nimodipine—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.000375	0.00972	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.000353	0.00914	CcSEcCtD
Nimodipine—Bradycardia—Prednisolone—ankylosing spondylitis	0.000342	0.00886	CcSEcCtD
Nimodipine—Sweating increased—Betamethasone—ankylosing spondylitis	0.000341	0.00883	CcSEcCtD
Nimodipine—Sweating increased—Dexamethasone—ankylosing spondylitis	0.000341	0.00883	CcSEcCtD
Nimodipine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000314	0.00815	CcSEcCtD
Nimodipine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000314	0.00813	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000311	0.00806	CcSEcCtD
Nimodipine—Sweating increased—Prednisone—ankylosing spondylitis	0.000297	0.00769	CcSEcCtD
Nimodipine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000286	0.00741	CcSEcCtD
Nimodipine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000285	0.00739	CcSEcCtD
Nimodipine—Bradycardia—Betamethasone—ankylosing spondylitis	0.000285	0.00739	CcSEcCtD
Nimodipine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000279	0.00724	CcSEcCtD
Nimodipine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000278	0.00721	CcSEcCtD
Nimodipine—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000272	0.00705	CcSEcCtD
Nimodipine—Depression—Prednisone—ankylosing spondylitis	0.000271	0.00702	CcSEcCtD
Nimodipine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000254	0.00659	CcSEcCtD
Nimodipine—Angiopathy—Betamethasone—ankylosing spondylitis	0.000254	0.00659	CcSEcCtD
Nimodipine—Hypertension—Prednisolone—ankylosing spondylitis	0.000252	0.00654	CcSEcCtD
Nimodipine—Bradycardia—Prednisone—ankylosing spondylitis	0.000248	0.00644	CcSEcCtD
Nimodipine—Oedema—Prednisolone—ankylosing spondylitis	0.000239	0.00618	CcSEcCtD
Nimodipine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000233	0.00603	CcSEcCtD
Nimodipine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000232	0.00601	CcSEcCtD
Nimodipine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000232	0.006	CcSEcCtD
Nimodipine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000231	0.00598	CcSEcCtD
Nimodipine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000229	0.00593	CcSEcCtD
Nimodipine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000228	0.00592	CcSEcCtD
Nimodipine—Depression—Methotrexate—ankylosing spondylitis	0.000226	0.00587	CcSEcCtD
Nimodipine—Flushing—Prednisone—ankylosing spondylitis	0.000226	0.00587	CcSEcCtD
Nimodipine—Angiopathy—Prednisone—ankylosing spondylitis	0.000221	0.00574	CcSEcCtD
Nimodipine—Immune system disorder—Prednisone—ankylosing spondylitis	0.00022	0.00571	CcSEcCtD
Nimodipine—Oedema—Triamcinolone—ankylosing spondylitis	0.000219	0.00568	CcSEcCtD
Nimodipine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000215	0.00557	CcSEcCtD
Nimodipine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000215	0.00556	CcSEcCtD
Nimodipine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000214	0.00555	CcSEcCtD
Nimodipine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000214	0.00554	CcSEcCtD
Nimodipine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000212	0.0055	CcSEcCtD
Nimodipine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000212	0.00548	CcSEcCtD
Nimodipine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000211	0.00546	CcSEcCtD
Nimodipine—Hypertension—Betamethasone—ankylosing spondylitis	0.000211	0.00546	CcSEcCtD
Nimodipine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000208	0.00538	CcSEcCtD
Nimodipine—Myalgia—Betamethasone—ankylosing spondylitis	0.000208	0.00538	CcSEcCtD
Nimodipine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000204	0.0053	CcSEcCtD
Nimodipine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000204	0.00528	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.0002	0.00518	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000199	0.00517	CcSEcCtD
Nimodipine—Oedema—Betamethasone—ankylosing spondylitis	0.000199	0.00516	CcSEcCtD
Nimodipine—Oedema—Dexamethasone—ankylosing spondylitis	0.000199	0.00516	CcSEcCtD
Nimodipine—Anaemia—Prednisone—ankylosing spondylitis	0.000196	0.00509	CcSEcCtD
Nimodipine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000196	0.00507	CcSEcCtD
Nimodipine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000195	0.00506	CcSEcCtD
Nimodipine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000195	0.00506	CcSEcCtD
Nimodipine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000195	0.00505	CcSEcCtD
Nimodipine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000195	0.00505	CcSEcCtD
Nimodipine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000194	0.00503	CcSEcCtD
Nimodipine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000194	0.00503	CcSEcCtD
Nimodipine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000192	0.00499	CcSEcCtD
Nimodipine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000192	0.00499	CcSEcCtD
Nimodipine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000189	0.0049	CcSEcCtD
Nimodipine—Hypotension—Betamethasone—ankylosing spondylitis	0.000186	0.00482	CcSEcCtD
Nimodipine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000186	0.00482	CcSEcCtD
Nimodipine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000185	0.00479	CcSEcCtD
Nimodipine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000184	0.00477	CcSEcCtD
Nimodipine—Hypertension—Prednisone—ankylosing spondylitis	0.000183	0.00475	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000181	0.0047	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000181	0.0047	CcSEcCtD
Nimodipine—Myalgia—Prednisone—ankylosing spondylitis	0.000181	0.00469	CcSEcCtD
Nimodipine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000176	0.00455	CcSEcCtD
Nimodipine—Oedema—Prednisone—ankylosing spondylitis	0.000173	0.00449	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000172	0.00445	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000172	0.00445	CcSEcCtD
Nimodipine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00017	0.0044	CcSEcCtD
Nimodipine—Tachycardia—Prednisone—ankylosing spondylitis	0.000169	0.00438	CcSEcCtD
Nimodipine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000168	0.00434	CcSEcCtD
Nimodipine—Anaemia—Methotrexate—ankylosing spondylitis	0.000164	0.00425	CcSEcCtD
Nimodipine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000162	0.00419	CcSEcCtD
Nimodipine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000161	0.00418	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000158	0.00409	CcSEcCtD
Nimodipine—Dizziness—Prednisolone—ankylosing spondylitis	0.000158	0.00409	CcSEcCtD
Nimodipine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000155	0.00402	CcSEcCtD
Nimodipine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000155	0.00401	CcSEcCtD
Nimodipine—Myalgia—Methotrexate—ankylosing spondylitis	0.000151	0.00392	CcSEcCtD
Nimodipine—Rash—Prednisolone—ankylosing spondylitis	0.00015	0.0039	CcSEcCtD
Nimodipine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00015	0.00389	CcSEcCtD
Nimodipine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00015	0.00388	CcSEcCtD
Nimodipine—Headache—Prednisolone—ankylosing spondylitis	0.000149	0.00387	CcSEcCtD
Nimodipine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000145	0.00376	CcSEcCtD
Nimodipine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000145	0.00375	CcSEcCtD
Nimodipine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000142	0.00368	CcSEcCtD
Nimodipine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000142	0.00368	CcSEcCtD
Nimodipine—Nausea—Prednisolone—ankylosing spondylitis	0.000142	0.00367	CcSEcCtD
Nimodipine—Pruritus—Betamethasone—ankylosing spondylitis	0.000141	0.00365	CcSEcCtD
Nimodipine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000141	0.00365	CcSEcCtD
Nimodipine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00014	0.00363	CcSEcCtD
Nimodipine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000139	0.00361	CcSEcCtD
Nimodipine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000139	0.00361	CcSEcCtD
Nimodipine—Rash—Triamcinolone—ankylosing spondylitis	0.000138	0.00358	CcSEcCtD
Nimodipine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000138	0.00358	CcSEcCtD
Nimodipine—Rash—Methylprednisolone—ankylosing spondylitis	0.000138	0.00358	CcSEcCtD
Nimodipine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000138	0.00357	CcSEcCtD
Nimodipine—Headache—Triamcinolone—ankylosing spondylitis	0.000137	0.00356	CcSEcCtD
Nimodipine—Headache—Methylprednisolone—ankylosing spondylitis	0.000137	0.00355	CcSEcCtD
Nimodipine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000136	0.00353	CcSEcCtD
Nimodipine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000136	0.00353	CcSEcCtD
Nimodipine—Hypotension—Methotrexate—ankylosing spondylitis	0.000135	0.00351	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000132	0.00342	CcSEcCtD
Nimodipine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000132	0.00341	CcSEcCtD
Nimodipine—Dizziness—Betamethasone—ankylosing spondylitis	0.000132	0.00341	CcSEcCtD
Nimodipine—Nausea—Triamcinolone—ankylosing spondylitis	0.00013	0.00338	CcSEcCtD
Nimodipine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00013	0.00337	CcSEcCtD
Nimodipine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000129	0.00335	CcSEcCtD
Nimodipine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000128	0.00331	CcSEcCtD
Nimodipine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000127	0.00328	CcSEcCtD
Nimodipine—Vomiting—Betamethasone—ankylosing spondylitis	0.000127	0.00328	CcSEcCtD
Nimodipine—Rash—Dexamethasone—ankylosing spondylitis	0.000125	0.00325	CcSEcCtD
Nimodipine—Rash—Betamethasone—ankylosing spondylitis	0.000125	0.00325	CcSEcCtD
Nimodipine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000125	0.00325	CcSEcCtD
Nimodipine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000125	0.00325	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000125	0.00324	CcSEcCtD
Nimodipine—Headache—Dexamethasone—ankylosing spondylitis	0.000125	0.00323	CcSEcCtD
Nimodipine—Headache—Betamethasone—ankylosing spondylitis	0.000125	0.00323	CcSEcCtD
Nimodipine—Pruritus—Prednisone—ankylosing spondylitis	0.000123	0.00318	CcSEcCtD
Nimodipine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000119	0.00307	CcSEcCtD
Nimodipine—Nausea—Dexamethasone—ankylosing spondylitis	0.000118	0.00306	CcSEcCtD
Nimodipine—Nausea—Betamethasone—ankylosing spondylitis	0.000118	0.00306	CcSEcCtD
Nimodipine—Dizziness—Prednisone—ankylosing spondylitis	0.000115	0.00297	CcSEcCtD
Nimodipine—Vomiting—Prednisone—ankylosing spondylitis	0.00011	0.00286	CcSEcCtD
Nimodipine—Rash—Prednisone—ankylosing spondylitis	0.000109	0.00283	CcSEcCtD
Nimodipine—Dermatitis—Prednisone—ankylosing spondylitis	0.000109	0.00283	CcSEcCtD
Nimodipine—Headache—Prednisone—ankylosing spondylitis	0.000109	0.00281	CcSEcCtD
Nimodipine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000107	0.00277	CcSEcCtD
Nimodipine—Nausea—Prednisone—ankylosing spondylitis	0.000103	0.00267	CcSEcCtD
Nimodipine—Pruritus—Methotrexate—ankylosing spondylitis	0.000102	0.00266	CcSEcCtD
Nimodipine—Diarrhoea—Methotrexate—ankylosing spondylitis	9.91e-05	0.00257	CcSEcCtD
Nimodipine—Dizziness—Methotrexate—ankylosing spondylitis	9.58e-05	0.00248	CcSEcCtD
Nimodipine—Vomiting—Methotrexate—ankylosing spondylitis	9.21e-05	0.00239	CcSEcCtD
Nimodipine—Rash—Methotrexate—ankylosing spondylitis	9.13e-05	0.00237	CcSEcCtD
Nimodipine—Dermatitis—Methotrexate—ankylosing spondylitis	9.12e-05	0.00236	CcSEcCtD
Nimodipine—Headache—Methotrexate—ankylosing spondylitis	9.07e-05	0.00235	CcSEcCtD
Nimodipine—Nausea—Methotrexate—ankylosing spondylitis	8.6e-05	0.00223	CcSEcCtD
